Showing 561 - 580 results of 7,454 for search '"Minimalism"', query time: 0.06s Refine Results
  1. 561
  2. 562

    Primary Retroperitoneal Approach to the Superior Mesenteric Vessels in Minimally Invasive Surgical Treatment of Right Colon Cancer with D3 Lymph Node Dissection.... by S. K. Efetov, B. S. Semchenko, A. K. Rychkova

    Published 2024-12-01
    “…The obtained results demonstrated the possibility of using this method for minimally invasive radical treatment of right colon cancer.…”
    Get full text
    Article
  3. 563
  4. 564
  5. 565

    Minimally Invasive Fetoscopic Resection of Life-Threatening Amniotic Band Constrictions in a Human Fetus at 22 + 2 Weeks of Gestation Complicated by Subtotal Chorioamniotic Separation and Partial Placental Abruption by Nadja Riehle, Oliver Nowak, Leila Messroghli, Samantha Wakerlin, Thomas Schaible, Thomas Kohl

    Published 2024-12-01
    “…Objectives: The purpose of this report is to present the surgical technique and outcome of a challenging percutaneous fetoscopic intervention in a human fetus with amniotic band constrictions of a fetal thigh, retroplacental hematoma, partial placental abruption, subtotal chorioamniotic separation, and multiple amniotic bands encircling the umbilical cord. Methods: Minimally invasive, fetoscopic surgery to salvage the fetal life and lower leg was performed at 22 + 2 weeks of gestation under general maternofetal anesthesia. …”
    Get full text
    Article
  6. 566
  7. 567
  8. 568

    Rare e14a3 (b3a3) BCR-ABL Fusion in Chronic Myeloid Leukemia in India: The Threats and Challenges in Monitoring Minimal Residual Disease (MRD) by Salil Vaniawala, Arpan Acharya, Harsh Parekh, Pratap N. Mukhopadhyaya

    Published 2013-01-01
    “…Objective: The primary objective of this work was to confirm the occurrence of rare BCR ABL fusion variant involving the a3 region of the ABL gene in a patient positive for t(9;22) translocation but negative for common major and minor breakpoint cluster regions and the challenges and threats that it poses in a routine laboratory setting which use commercial kits for monitoring the minimal residual disease.…”
    Get full text
    Article
  9. 569
  10. 570
  11. 571
  12. 572
  13. 573
  14. 574
  15. 575
  16. 576
  17. 577
  18. 578
  19. 579
  20. 580